Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Nucleic acid molecules encoding an engineered antigen receptor and an inhibitory nucleic acid molecule and methods of use thereof

Nucleic acid molecules encoding an engineered antigen receptor and an inhibitory nucleic acid molecule and methods of use thereof

US Patent 10745665 · Granted Aug 18, 2020

Estimated economic value: $7,570,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Genetically-modified T cells comprising a modified intron in the T cell receptor2025
Genetically-modified T cells comprising a modified intron in the T cell receptor2025
Rationally-designed single-chain meganucleases with non-palindromic recognition 2025
Methods for producing a complex transgenic trait locus2025
Polynucleotides encoding engineered meganucleases having specificity for recogni2024
Polynucleotides encoding engineered meganucleases having specificity for recogni2024
Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)2023
Polynucleotides encoding engineered meganucleases having specificity for recogni2023
Engineered meganucleases specific for recognition sequences in the PCSK9 gene2023
Methods for producing a complex transgenic trait locus2022
Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)2022
Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)2022